Filters
Targeting BCR signalosome in B-cell malignancies (NV17-31834A)
The B-cell receptor (BCR) signalling pathway is tightly connected with the function, proliferation and survival of B cells. Aberrant BCR signalling, typical for various B cell malignancies
FD - Onkologie a hematologie
- 2017 - 2020 •
- 9 122 tis. Kč •
- 9 122 tis. Kč •
- MZ
Řešení projektu: 1. 4. 2017 - 31. 12. 2020
Uznané náklady
Podpora ze státního rozpočtu (100%)
Poskytovatel: Ministerstvo zdravotnictví
Cellular Aging in haematological malignancy (NT14310)
by whole genome assay for B cell progenitors in young and old healthy donors. The aging-biomarkers for B cell progenitors will be identified. B cell aging-diagnostic panel will be generated and v...
FD - Onkologie a hematologie
- 2013 - 2015 •
- 8 570 tis. Kč •
- 8 511 tis. Kč •
- MZ
Řešení projektu: 1. 5. 2013 - 31. 12. 2015
Uznané náklady
Podpora ze státního rozpočtu (99%)
Poskytovatel: Ministerstvo zdravotnictví
Composition of immunocompetent cells in targeted therapy in pediatric acute lymphoblastic leukemia and lymphoma (NU23-05-00353)
of utmost importance. Targeting specific structures on malignant B cells also influences non-malignant cells. Knowledge about immune reconstitution is essential for identification of patients with preexis...
Immunology
- 2023 - 2026 •
- 11 022 tis. Kč •
- 11 022 tis. Kč •
- MZ
Řešení projektu: 1. 5. 2023 - 31. 12. 2026
Uznané náklady
Podpora ze státního rozpočtu (100%)
Poskytovatel: Ministerstvo zdravotnictví
Phenotype feature of B cells and plasma cells and its association with malignant transformation in monoclonal gammopathies (NS10408)
Flow cytometric analysis of B cells and plasma cells subtypes in healthy volunteers and monoclonal gammopathy patients. Identification of clonal cells in compartment of plasma cells or B cells...
FD - Onkologie a hematologie
- 2009 - 2011 •
- 3 582 tis. Kč •
- 3 582 tis. Kč •
- MZ
Řešení projektu: 1. 1. 2009 - 31. 12. 2011
Uznané náklady
Podpora ze státního rozpočtu (100%)
Poskytovatel: Ministerstvo zdravotnictví
New approaches to Chimeric Antigen Receptor T cells analysis of RASAL3 protein function and identification of novel CAR-T activity-modifying genes (GA22-35273S)
Chimeric Antigen Receptor (CAR) T cells achieved remarkable success in treating B-cell malignancies, yet, their long term efficiency does not hold up to the original promises. Novel designs of CAR-T cells ...
Technologies involving the manipulation of cells, tissues, organs or the whole organism (assisted reproduction)
- 2022 - 2024 •
- 8 916 tis. Kč •
- 8 814 tis. Kč •
- GA ČR
Řešení projektu: 1. 1. 2022 - 31. 12. 2024
Uznané náklady
Podpora ze státního rozpočtu (99%)
Poskytovatel: Grantová agentura České republiky
Molecular mechanisms of signaling through leukocyte receptors their role in health and disease. (GBP302/12/G101)
). Functional analysis of human B-cell development and B-cell receptor assembly and editing and B-cell interplay with T-lymphocytes in relation to B cell malignant of im...
EC - Imunologie
- 2012 - 2018 •
- 75 061 tis. Kč •
- 75 061 tis. Kč •
- GA ČR
Řešení projektu: 1. 1. 2012 - 31. 12. 2018
Uznané náklady
Podpora ze státního rozpočtu (100%)
Poskytovatel: Grantová agentura České republiky
THE IMPACT OF THERAPEUTIC TARGETING OF BCR SIGNALLING ON GENE EXPRESSION IN B CELL MALIGNANCIES AND ITS PROGNOSTIC AND PREDICTIVE SIGNIFICANCE (NV16-29622A)
The clinical use of BCR-inhibitors in B cell malignancies has promising clinical effects; however, better understanding is needed to design combinatorial treatments, and to understand their mechanisms of action and molecula...
FD - Onkologie a hematologie
- 2016 - 2019 •
- 9 899 tis. Kč •
- 9 899 tis. Kč •
- MZ
Řešení projektu: 1. 4. 2016 - 31. 12. 2019
Uznané náklady
Podpora ze státního rozpočtu (100%)
Poskytovatel: Ministerstvo zdravotnictví
Influence of Toll-like Receptor Agonists on Immunogenicity of Tumour Cells in B cell Chronic Lymphocytic Leukemia (GP310/08/P353)
that enhance the immunogenicity of B-CLL cells may be useful in immunotherapeutic approaches to this disease. Non-malignant B cells express broad spectrum of Toll-like incurable with conventional therapy....
EC - Imunologie
- 2008 - 2010 •
- 1 230 tis. Kč •
- 1 230 tis. Kč •
- GA ČR
Řešení projektu: 1. 1. 2008 - 31. 12. 2010
Uznané náklady
Podpora ze státního rozpočtu (100%)
Poskytovatel: Grantová agentura České republiky
ROR1-positive peripheral blood b-cells of healthy donors and their connection to chronic lymphocytic leukemia development (GA23-05561S)
+ B cells were described, however our data show that these populations contain also mature B cells, including memory subsets. We will analyze these populations together with peripheral B cells of ...
Cell biology
- 2023 - 2025 •
- 10 232 tis. Kč •
- 10 232 tis. Kč •
- GA ČR
Řešení projektu: 1. 3. 2023 - 31. 12. 2025
Uznané náklady
Podpora ze státního rozpočtu (100%)
Poskytovatel: Grantová agentura České republiky
Molecular Characterization of B-cell Receptors and Their Relationship to Evolution of Gemonic Aberrations in Chronic Lymphocytic Leukemia (NT13493)
factors. The signalization via B-cell receptor (BCR) belongs among them; its intensity potential of malignant cells which influence heterogeneous accumulation of genetic single-cell multiplex PCR for comp...
FD - Onkologie a hematologie
- 2012 - 2015 •
- 8 737 tis. Kč •
- 8 737 tis. Kč •
- MZ
Řešení projektu: 1. 4. 2012 - 31. 12. 2015
Uznané náklady
Podpora ze státního rozpočtu (100%)
Poskytovatel: Ministerstvo zdravotnictví
- 1 - 10 out of 6 473